Literature DB >> 24966195

Sex-based differences in HIV type 1 pathogenesis.

Marylyn M Addo1, Marcus Altfeld2.   

Abstract

Human immunodeficiency virus (HIV) remains a global infectious diseases threat that disproportionally affects women. Beyond social and political factors, biological and genetic differences have been identified that lead to differential disease courses and outcomes in men and women. Following HIV type 1 (HIV-1) seroconversion, women have up to 40% lower HIV loads and higher CD4(+) T-cell counts than men. However, at the same level of viremia, progression to AIDS is faster in women. After adjustment for viral load, HIV-positive women also display increased levels of generalized immune activation and experience the consequences of elevated inflammatory activity more frequently than men. Part of these observations are linked to sex-based differences in innate immunity, in which the differential ability of plasmacytoid dendritic cells to produce interferon α following stimulation of Toll-like receptor 7 and upregulation of interferon-stimulated genes play a central role. Here, we review the current knowledge and remaining gaps therein regarding sex-based differences in HIV-1 pathogenesis.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV-1; ISG; Immune activation; interferon-alpha; sex

Mesh:

Substances:

Year:  2014        PMID: 24966195      PMCID: PMC4157516          DOI: 10.1093/infdis/jiu175

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  53 in total

1.  Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.

Authors:  Julian Schulze Zur Wiesch; Adriana Thomssen; Philip Hartjen; Ilona Tóth; Clara Lehmann; Dirk Meyer-Olson; Kristina Colberg; Sebastian Frerk; Dalia Babikir; Stefan Schmiedel; Olaf Degen; Stefan Mauss; Jürgen Rockstroh; Schlomo Staszewski; Pavel Khaykin; Alexander Strasak; Ansgar W Lohse; Gerd Fätkenheuer; Joachim Hauber; Jan van Lunzen
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

2.  Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine.

Authors:  Kimberly Y Smith; Camlin Tierney; Katie Mollan; Charles S Venuto; Chakra Budhathoki; Qing Ma; Gene D Morse; Paul Sax; David Katzenstein; Catherine Godfrey; Margaret Fischl; Eric S Daar; Ann C Collier
Journal:  Clin Infect Dis       Date:  2013-11-18       Impact factor: 9.079

3.  Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population.

Authors:  Sylvie Lang; Murielle Mary-Krause; Laurent Cotte; Jacques Gilquin; Marialuisa Partisani; Anne Simon; Franck Boccara; Annie Bingham; Dominique Costagliola
Journal:  AIDS       Date:  2010-05-15       Impact factor: 4.177

4.  Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection.

Authors:  Amie L Meditz; Samantha MaWhinney; Amanda Allshouse; William Feser; Martin Markowitz; Susan Little; Richard Hecht; Eric S Daar; Ann C Collier; Joseph Margolick; J Michael Kilby; Jean-Pierre Routy; Brian Conway; John Kaldor; Jay Levy; Robert Schooley; David A Cooper; Marcus Altfeld; Douglas Richman; Elizabeth Connick
Journal:  J Infect Dis       Date:  2011-01-18       Impact factor: 5.226

5.  Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1.

Authors:  Angela Meier; J Judy Chang; Ellen S Chan; Richard B Pollard; Harlyn K Sidhu; Smita Kulkarni; Tom Fang Wen; Robert J Lindsay; Liliana Orellana; Donna Mildvan; Suzane Bazner; Hendrik Streeck; Galit Alter; Jeffrey D Lifson; Mary Carrington; Ronald J Bosch; Gregory K Robbins; Marcus Altfeld
Journal:  Nat Med       Date:  2009-07-13       Impact factor: 53.440

6.  Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

Authors:  Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Joseph Chiu; Robert Paris; Nakorn Premsri; Chawetsan Namwat; Mark de Souza; Elizabeth Adams; Michael Benenson; Sanjay Gurunathan; Jim Tartaglia; John G McNeil; Donald P Francis; Donald Stablein; Deborah L Birx; Supamit Chunsuttiwat; Chirasak Khamboonruang; Prasert Thongcharoen; Merlin L Robb; Nelson L Michael; Prayura Kunasol; Jerome H Kim
Journal:  N Engl J Med       Date:  2009-10-20       Impact factor: 91.245

7.  X chromosomal variation is associated with slow progression to AIDS in HIV-1-infected women.

Authors:  Roman A Siddiqui; Ulrike Sauermann; Janine Altmüller; Elfriede Fritzer; Michael Nothnagel; Nina Dalibor; Jacques Fellay; Franz-Josef Kaup; Christiane Stahl-Hennig; Peter Nürnberg; Michael Krawczak; Matthias Platzer
Journal:  Am J Hum Genet       Date:  2009-08       Impact factor: 11.025

8.  Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9.

Authors:  Cristiana Guiducci; Claudio Tripodo; Mei Gong; Sabina Sangaletti; Mario P Colombo; Robert L Coffman; Franck J Barrat
Journal:  J Exp Med       Date:  2010-11-29       Impact factor: 14.307

9.  Resting regulatory CD4 T cells: a site of HIV persistence in patients on long-term effective antiretroviral therapy.

Authors:  Tu-Anh Tran; Marie-Ghislaine de Goër de Herve; Houria Hendel-Chavez; Bamory Dembele; Emilie Le Névot; Karim Abbed; Coralie Pallier; Cécile Goujard; Jacques Gasnault; Jean-François Delfraissy; Anne-Marie Balazuc; Yassine Taoufik
Journal:  PLoS One       Date:  2008-10-01       Impact factor: 3.240

Review 10.  The X-files in immunity: sex-based differences predispose immune responses.

Authors:  Eleanor N Fish
Journal:  Nat Rev Immunol       Date:  2008-09       Impact factor: 53.106

View more
  73 in total

Review 1.  Sex Differences in Select Non-communicable HIV-Associated Comorbidities: Exploring the Role of Systemic Immune Activation/Inflammation.

Authors:  Avanthi Raghavan; Dodie E Rimmelin; Kathleen V Fitch; Markella V Zanni
Journal:  Curr HIV/AIDS Rep       Date:  2017-12       Impact factor: 5.071

Review 2.  New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design.

Authors:  Thomas Musich; Marjorie Robert-Guroff
Journal:  Expert Rev Vaccines       Date:  2016-03-16       Impact factor: 5.217

3.  International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK.

Authors: 
Journal:  J Int AIDS Soc       Date:  2016-10-23       Impact factor: 5.396

4.  Differences in Cognitive Function Between Women and Men With HIV.

Authors:  Pauline M Maki; Leah H Rubin; Gayle Springer; Eric C Seaberg; Ned Sacktor; Eric N Miller; Victor Valcour; Mary A Young; James T Becker; Eileen M Martin
Journal:  J Acquir Immune Defic Syndr       Date:  2018-09-01       Impact factor: 3.731

5.  Impact of Biological Sex on Immune Activation and Frequency of the Latent HIV Reservoir During Suppressive Antiretroviral Therapy.

Authors:  Shane D Falcinelli; Bonnie E Shook-Sa; Morgan G Dewey; Sumati Sridhar; Jenna Read; Jennifer Kirchherr; Katherine S James; Brigitte Allard; Simon Ghofrani; Erin Stuelke; Caroline Baker; Nadia R Roan; Joseph J Eron; JoAnn D Kuruc; Catalina Ramirez; Cynthia Gay; Katie R Mollan; David M Margolis; Adaora A Adimora; Nancie M Archin
Journal:  J Infect Dis       Date:  2020-11-09       Impact factor: 5.226

6.  Nef-mediated inhibition of NFAT following TCR stimulation differs between HIV-1 subtypes.

Authors:  Lisa Naidoo; Zinhle Mzobe; Steven W Jin; Erasha Rajkoomar; Tarylee Reddy; Mark A Brockman; Zabrina L Brumme; Thumbi Ndung'u; Jaclyn K Mann
Journal:  Virology       Date:  2019-02-21       Impact factor: 3.616

7.  Early SIV and HIV infection promotes the LILRB2/MHC-I inhibitory axis in cDCs.

Authors:  Lamine Alaoui; Gustavo Palomino; Sandy Zurawski; Gerard Zurawski; Sixtine Coindre; Nathalie Dereuddre-Bosquet; Camille Lecuroux; Cecile Goujard; Bruno Vaslin; Christine Bourgeois; Pierre Roques; Roger Le Grand; Olivier Lambotte; Benoit Favier
Journal:  Cell Mol Life Sci       Date:  2017-11-13       Impact factor: 9.261

8.  Sex Differences in Plasmacytoid Dendritic Cell Levels of IRF5 Drive Higher IFN-α Production in Women.

Authors:  Morgane Griesbeck; Susanne Ziegler; Sophie Laffont; Nikaïa Smith; Lise Chauveau; Phillip Tomezsko; Armon Sharei; Georgio Kourjian; Filippos Porichis; Meghan Hart; Christine D Palmer; Michael Sirignano; Claudia Beisel; Heike Hildebrandt; Claire Cénac; Alexandra-Chloé Villani; Thomas J Diefenbach; Sylvie Le Gall; Olivier Schwartz; Jean-Philippe Herbeuval; Brigitte Autran; Jean-Charles Guéry; J Judy Chang; Marcus Altfeld
Journal:  J Immunol       Date:  2015-10-30       Impact factor: 5.422

Review 9.  Sex, age, race and intervention type in clinical studies of HIV cure: a systematic review.

Authors:  Rowena E Johnston; Mary M Heitzeg
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

10.  Dual TLR2 and TLR7 agonists as HIV latency-reversing agents.

Authors:  Amanda B Macedo; Camille L Novis; Caroline M De Assis; Eric S Sorensen; Paula Moszczynski; Szu-Han Huang; Yanqin Ren; Adam M Spivak; R Brad Jones; Vicente Planelles; Alberto Bosque
Journal:  JCI Insight       Date:  2018-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.